News

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...
A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.
A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...
Researchers from Memorial Sloan Kettering Cancer Center and the University of California, Los Angeles, identified that ...
Research in Mayo Clinic's Liver Disease Immunobiology Lab led by Petra Hirsova, Pharm.D., Ph.D., focuses on metabolic dysfunction-associated steatohepatitis.
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
Liver cancer poses significant challenges due to its complex causes and resistance to conventional treatments, highlighting the need for innovative ...
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.